FDA cleared the Fast PCR Mini Respiratory Panel from Autonomous Medical Devices Incorporated on Jun 12, 2026 under K252932, a dual track 510(k). The device falls under product code QOF, Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents, regulated at 21 CFR 866.3981 as a Class 2 device. The review panel was Microbiology.

FDA logged the submission as received on Sep 15, 2025. The decision came 270 days later, longer than the 90 FDA-day review goal, which usually means at least one additional information request.

This is the only decision on file for Autonomous Medical Devices Incorporated in the last 12 months of the tracker.